Ultimately, the decision is up to you
Gastrointestinal side effects are very common with GLP-1 medications, with nausea, vomiting, diarrhoea and constipation frequently reported
Molecular remedy of complex I defects: rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells
It has not received FDA approval for any indication
How to Use / Administration Methods GHRP-6 is administered via subcutaneous injection, typically into abdominal fat, the thigh, or the deltoid region
"Anything that helps patients get access and affordability, we are in support of," Jrgensen responds